Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
Alhiary R, Kesselheim AS, Gabriele S, et al.
JAMA. Pub. online 28 Jul 2023.
Leggi
Breaking news
Effects of sodium-glucose co-transporter 2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis
Avgerinos I, Karagiannis T, Matthews DR, et al.
Diabetes Obes Metab. Pub. online 12 Jul 2023.
Leggi
Evaluation of insulin pump infusion sites in type 1 diabetes: the DERMIS study
Kalus A; Shinohara MM, Wang R, et al.
Diabetes Care. 2023 Jul 14;dc230426.
Leggi
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry
Bassand JP, Virdone S, Camm AJ, et al.
Diabetes Obes Metab. Pub. online 12 Jul 2023.
Leggi
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
Sacks DB, Arnold M, Bakris GL, et al.
Diabetes Care. 2023;dci230036
Leggi
The Advanced Hybrid Closed Loop Improves Glycemia Risk Index (GRI), Continuous Glucose Monitoring Index (COGI), and Time in Range (TIR) in Children with Type 1 Diabetes: Real-world Data from a Single Center Study
Eviz E,Dr. Mutlu GY, Karakuş KE, et al.
Diabetes Technol Ther. Pub. online Jul 14 2023.
Leggi
An unwelcome inheritance: childhood obesity after diabetes in pregnancy
Meek CL
Diabetologia. Pub. online Jul 13 2023.
Leggi
Utility of genetic risk scores in type 1 diabetes
Luckett AM, Weedon MN, Hawkes G, et al.
Diabetologia. Pub. online Jul 13 2023.
Leggi
Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study
Iwakura H, Takagi T, Inaba H, et al.
BMC Endocr Disord. 2023;23(1):146.
Leggi
A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects
Lee MMY, Sattar N
Diabetes Obes Metab. 2023;25 Suppl 3:33-47.
Leggi